For condition: Hidradenitis Suppurativa
Adult’s Hidradenitis Suppurativa Study (61 Weeks)
Study Summary
Who Can Participate?
People aged 18 and above with moderate to severe Hidradenitis Suppurativa (HS) may participate.
Inclusion Criteria
- Participants must have signs and symptoms of HS for at least 6 months
- Diagnosis of HS, with stable HS signs and symptoms for 2 months
- Participants must have a history of inadequate response to a previous course of oral antibiotic for treatment of HS or exhibited recurrence, intolerance, or contraindication during that course of oral antibiotic
Participant Information
- Participate and receive study treatment at no cost
- Regular visits with study doctors who specialise in treating Hidradenitis Suppurativa (up to 12 visits)
- Will receive either an investigative oral treatment (study drug) or a placebo
- Reimbursement for study-related expenses may be provided
How Long Will The Study Last?
- Approximately 61 weeks
For more information about this trial, please visit ClinicalTrials.gov
